This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinates of Health
        • Disparities: Social Determinates of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinates of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASCO GU 2023
      • EAU 2023
      • SES AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer
  5. Conferences
  6. EAU 2014

EAU 2014 - Prostate Cancer

Recent Abstracts
EAU 2014 - Poster: Safety and efficacy of ODM-201 in chemotherapy and CYP17-inhibitor naïve patients: Analysis of data from the ARADES and the ARAFOR trials April 16, 2014
EAU 2014 - Poster: Greater short-term relief of lower urinary tract symptoms in prostate cancer patients treated with degarelix compared to goserelin plus bicalutamide: Results of a pooled analysis April 16, 2014
EAU 2014 - Poster: Nadir testosterone on ADT predicts for time to castrate resistant progression: A secondary analysis of the PR-7 intermittent vs continuous ADT trial April 16, 2014
EAU 2014 - Effects of prior use of statins in a phase 3 study of intermittent versus continuous combined androgen deprivation - Session Highlights April 15, 2014
EAU 2014 - Nadir testosterone on ADT predicts for time to castrate resistant progression: A secondary analysis of the PR-7 intermittent vs continuous ADT trial - Session Highlights April 15, 2014
EAU 2014 - Survival benefit of radical prostatectomy in patients with clinically advanced prostate cancer: Estimations of the number needed to treat based on competing-risks analysis - Session Highlights April 14, 2014
EAU 2014 - Is the striated urethral sphincter at risk by standard suture ligation of the dorsal vein complex in radical prostatectomy? An anatomical study in adult human male cadavers - Session Highlights April 14, 2014
EAU 2014 - Early start of oral sildenafil 100mg for erectile dysfunction after robotic assisted laparoscopic radical prostatectomy: Preliminary results from randomized prospective trial - Session Highlights April 14, 2014
EAU 2014 - A prospective comparison of transrectal ultrasound biopsy with an MRI based diagnostic strategy in men with suspicion of prostate cancer - Session Highlights April 14, 2014
EAU 2014 - Role of repeat 3T multiparametric MR imaging and MR-guided biopsy versus repeat TRUS-guided biopsies after 1 year follow-up in low-risk prostate cancer patients in an active surveillance protocol - Session Highlights April 14, 2014
EAU 2014 - Assessing the optimal postoperative management of node positive prostate cancer patients: Results from a large, multi-institutional series - Session Highlights April 14, 2014
EAU 2014 - The added value of intracorporeal urinary diversion after robotic radical cystectomy: A propensity matched comparative study - Session Highlights April 14, 2014
EAU 2014 - Protocol based versus non-protocol based discontinuation in the Prostate Cancer Research International: Active Surveillance (PRIAS) study - Session Highlights April 14, 2014
EAU 2014 - Active surveillance in 853 men with low and intermediate risk prostate cancer - Session Highlights April 14, 2014
EAU 2014 - EAU Guidelines snapshot: Testosterone supplementation and prostate cancer - Session Highlights April 14, 2014
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free